The supervisory board of Siemens Healthineers AG has unanimously and ahead of schedule extended the mandates of Chief Executive Officer Bernd Montag and Chief Financial Officer Jochen Schmitz by five years. Their contracts now run until the end of February 2031.
“I am very pleased that Bernd Montag and Jochen Schmitz have agreed to extend their mandates to further drive the development of this great company. Following the IPO in 2018, the managing board team has gradually established Siemens Healthineers as one of the world’s most important medtech companies and one of the ten most valuable companies in the German DAX share index. I very much look forward to the next chapter of this success story,” said Ralf P. Thomas, chair of the supervisory board of Siemens Healthineers AG.
Further information on Siemens Healthineers management can be found here.